Agrawal, A. and Bhosale, U.A. 2018. A prospective pharmacovigilance study to evaluate adverse effect profile of first line anti-tubercular drugs in newly diagnosed sputum positive patients. International Journal of Basic & Clinical Pharmacology. 7, 2 (Jan. 2018), 283–287. DOI:https://doi.org/10.18203/2319-2003.ijbcp20180099.